featured
Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
J. Clin. Oncol 2019 Feb 27;[EPub Ahead of Print], C Lebbé, N Meyer, L Mortier, I Marquez-Rodas, C Robert, P Rutkowski, AM Menzies, T Eigentler, PA Ascierto, M Smylie, D Schadendorf, M Ajaz, IM Svane, R Gonzalez, L Rollin, J Lord-Bessen, A Saci, E Grigoryeva, J PigozzoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.